Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000164

Chief Financial Officer bought 5,000 shares at $3.03 ($15,127)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tan Kevin Chief Financial Officer 2021-12-02 Purchase +5,000 $3.03 $15,127 5,000 D
Open-market purchases · 5,000 sh · avg $3.03 · $15,127
Loading xslF345X03/wf-form4_163882593226916.xml…